𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination Therapy of Active HBsAg Vaccination and Interferon-α in Interferon-α Nonresponders with Chronic Hepatitis B

✍ Scribed by Tobias Heintges; Wolfgang Petry; Michaela Kaldewey; Andreas Erhardt; Ulrike C. Wend; Wolfram H. Gerlich; Claus Niederau; Dieter Hãussinger

Book ID
110295062
Publisher
Springer US
Year
2001
Tongue
English
Weight
80 KB
Volume
46
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loss of HBsAg with interferon-α therapy
Loss of HBsAg with interferon-α therapy in chronic hepatitis D virus infection
✍ Johnson Y. N. Lau; Ruth King; Christopher J. Tibbs; Adrian P. Catterall; Heather 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

Eleven patients with chronic hepatitis D virus (HDV) infection who had chronic active hepatitis and HDV antigen on liver biopsy were randomised in a crossover therapeutic trial of interferon-alpha 2b vs. no therapy. Nine patients had a history of intravenous drug use (drug free > 6 months before the

Therapy for chronic hepatitis B with lym
Therapy for chronic hepatitis B with lymphoblastoid interferon-α and levamisole
✍ Giovanna Fattovich; Giuliano Giustina; Lucio Brollo; Maria Guido; Patrizia Ponti 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

About one third of patients with chronic hepatitis B show a sustained response when treated with interfer0n-u. Combining interferon-a with immuno- modulators might be a way to increase reaponse rate. The aim of thie study was to compare the ef6cacy of lymphoblaetaid interferons given alone with its